COMPANY NEWS


loading
Aurobindo Pharma Ltd
BSE Code 524804 ISIN Demat INE406A01037 Book Value (₹) 369.16 Div & Yield % 0 Market Cap ( Cr.) 68,819.18 P/E * 32.1 EPS * 36.91 Face Value (₹) 1
* Profit to Earning Ratio
* Earning Per Share
USFDA issues EIR for Unit 1 of Apitoria Pharma Back
(14 Nov 2025)
Aurobindo Pharma has received the Establishment Inspection Report (EIR) issued by the USFDA classifying Unit 1 of Apitoria Pharma, a wholly owned subsidiary of the company as 'Voluntary Action Indicated (VAI)'.